Health Canada
Symbol of the Government of Canada
Consumer Product Safety

Incident Report

Subform I: General Information

1. Report Type.

New incident report

Incident Report Number: 2020-2258

2. Registrant Information.

Registrant Reference Number: 2019-CA-000039

Registrant Name (Full Legal Name no abbreviations): The Hartz Mountain Corporation

Address: 400 Plaza Drive

City: Secaucus

Prov / State: New Jersey

Country: USA

Postal Code: 07094-3688

3. Select the appropriate subform(s) for the incident.

Domestic Animal

4. Date registrant was first informed of the incident.


5. Location of incident.

Country: CANADA

Prov / State: ALBERTA

6. Date incident was first observed.


Product Description

7. a) Provide the active ingredient and, if available, the registration number and product name (include all tank mixes). If the product is not registered provide a submission number.


PMRA Registration No. 29930      PMRA Submission No.       EPA Registration No.

Product Name: Hartz UltraGuard OneSpot Flea and Tick Cat Drops

  • Active Ingredient(s)

7. b) Type of formulation.

Application Information

8. Product was applied?


9. Application Rate.


10. Site pesticide was applied to (select all that apply).

Site: Animal / Usage sur un animal domestique

11. Provide any additional information regarding application (how it was applied, amount applied, the size of the area treated etc).

Please refer to field 13 on Subform II or field 17 of subform III for a detailed description regarding application.

To be determined by Registrant

12. In your opinion, was the product used according to the label instructions?


Subform III: Domestic Animal Incident Report

1. Source of Report

Animal's Owner

2. Type of animal affected

Cat / Chat

3. Breed

Domestic Shorthair

4. Number of animals affected


5. Sex


6. Age (provide a range if necessary )


7. Weight (provide a range if necessary )



8. Route(s) of exposure


9. What was the length of exposure?

Unknown / Inconnu

10. Time between exposure and onset of symptoms

>1 wk <=1 mo / > 1 sem < = 1 mois

11. List all symptoms


  • Skin
    • Symptom - Pruritus
    • Symptom - Dry skin
    • Symptom - Lesion
    • Symptom - Irritated skin
  • General
    • Symptom - Licking
  • Skin
    • Symptom - Dermatitis

12. How long did the symptoms last?

Unknown / Inconnu

13. Was medical treatment provided? Provide details in question 17.


14. a) Was the animal hospitalized?


14. b) How long was the animal hospitalized?

15. Outcome of the incident


16. How was the animal exposed?

Treatment / Traitement

17. Provide any additional details about the incident

(eg. description of the frequency and severity of the symptoms

On approximately 28-May-2019, an 8 year old, 15 pound, neutered, male, Domestic Shorthair cat, in unknown condition, with no known concomitant medical condition, was administered 1 tube of Hartz UltraGuard OneSpot Flea and Tick Cat Drops (S Methoprene) via the topical route by the animal owner. On approximately 14-Jun-2019, the cat developed an application site skin lesion, generalized pruritus, generalized skin irritation, localized dry skin and localized dermatitis on the abdomen, and licking its abdomen. The cat was evaluated by a veterinarian and no treatment was performed. On 24-Jun-2019, the cat was evaluated by a different veterinarian and they shaved an unspecified area of fur, applied an Elizabethan collar, prescribed an unknown amount of prednisolone and also a different unspecified flea and tick topical product that was to be applied once the clinical signs resolved. The clinical signs continued. No further information was received in this case.

To be determined by Registrant

18. Severity classification (if there is more than 1 possible classification


19. Provide supplemental information here

Assessment: Skin lesions or open skin are not anticipated simply from application of the product, but if the cat has been persistently scratching at a certain area, skin damage and an open sore may occur. Hypersensitivity can occur with any topical product and may be related to either the product's active or inactive ingredients. Given the delayed onset of signs, other causes including atopic dermatitis, food allergies, and ectoparasites should also be considered as potential causes. The information contained in this report is based on self-reported statements provided to the registrant during telephone Interview(s). These self-reported descriptions of an incident have not been independently verified to be factually correct or complete descriptions of the incident. For that reason, information contained in this report does not and can not form the basis for a determination of whether the reported clinical effects are causally related to exposure to the product identified in the telephone interviews.